ArticleMedicine2017

Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report.

Wenli Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.